|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 273, Issue 2 348-G354, Copyright © 1997 by American Physiological Society
ARTICLES |
H. Ogata and D. K. Podolsky
Gastrointestinal Unit, Massachusetts General Hospital, Boston, USA.
Trefoil peptides are a family of small proteins expressed by goblet cells that are secreted onto the apical gastrointestinal mucosal surface, where they are present in high concentrations. These peptides appear to both protect the epithelium and promote healing after injury. However, the factors regulating the expression and secretion of these proteins contributing to mucosal defense have not been characterized. To determine the mechanisms controlling production of trefoil peptides, the human colon cancer-derived model cell line HT-29 was exposed to a variety of potential secretagogues. Expression and secretion of human intestinal trefoil factor (hITF) as well as the intestinal apomucin MUC2 were assessed by Northern and Western blot analysis. Carbachol, an analog of acetylcholine, and the neuroendocrine peptides somatostatin and vasoactive intestinal polypeptide (VIP) stimulated increased expression of hITF mRNA within 5 min. These same factors stimulated parallel secretion of the hITF peptide, with maximal stimulation observed at concentrations ranging from 10(-6) M (carbachol and somatostatin) to 10(-7) M (VIP). Expression and secretion of hITF in response to carbachol, VIP, and somatostatin was independent of production of apomucin. hITF was not regulated by other neuroendocrine transmitters including histamine and substance P. Similarly, hITF expression and secretion was not modulated by peptide growth factors (epidermal growth factor, transforming growth factor-beta, and keratinocyte growth factor), cytokines [interleukin (IL)-1 beta, IL-2, IL-7, and IL-11], or arachidonic acid metabolites (prostaglandin E1/E2 and leukotriene B4). In conclusion, trefoil peptides appear to be integrated into mechanisms of mucosal defense and repair through the enteric neuroendocrine system and independent of the classical mucosal immune cytokine network.
This article has been cited by other articles:
![]() |
R. Hokari, H. Lee, S. C. Crawley, S. C. Yang, J. R. Gum Jr, S. Miura, and Y. S. Kim Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1 Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G949 - G959. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Vestergaard, S. S. Poulsen, H. Gronbaek, R. Larsen, A. M. Nielsen, K. Ejskjaer, J. T. Clausen, L. Thim, and E. Nexo Development and Evaluation of an ELISA for Human Trefoil Factor 3 Clin. Chem., October 1, 2002; 48(10): 1689 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. White Trefoil Peptides in Airway Epithelium . An Important Addition to the Plethora of Peptides Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 401 - 404. [Full Text] [PDF] |
||||
![]() |
D. Iwakiri and D. K. Podolsky A silencer inhibitor confers specific expression of intestinal trefoil factor in gobletlike cell lines Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1114 - G1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J I Semple, J L Newton, B R Westley, and F E B May Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice Gut, May 1, 2001; 48(5): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Furuta, J. R. Turner, C. T. Taylor, R. M. Hershberg, K. Comerford, S. Narravula, D. K. Podolsky, and S. P. Colgan Hypoxia-inducible Factor 1-dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia J. Exp. Med., April 30, 2001; 193(9): 1027 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Fallon, P. Smith, E. J. Richardson, F. J. Jones, H. C. Faulkner, J. Van Snick, J.-C. Renauld, R. K. Grencis, and D. W. Dunne Expression of Interleukin-9 Leads to Th2 Cytokine-Dominated Responses and Fatal Enteropathy in Mice with Chronic Schistosoma mansoni Infections Infect. Immun., October 1, 2000; 68(10): 6005 - 6011. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Tran, M. Familari, L. M. Parker, R. H. Whitehead, and A. S. Giraud Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G85 - G94. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |